Market Overview:
The global malaria drugs market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of malaria, rising demand for new and innovative drugs, and growing investments by key players in this market. The global malaria drugs market is segmented on the basis of type into aryl aminoalcohol compounds, antifolate compounds, and artemisinin compounds. The aryl aminoalcohol compound segment is expected to grow at the highest CAGR during the forecast period from 2018 to 2030. This growth can be attributed to the high efficacy and safety profile of these drugs compared with other drug types available in this market. On the basis of application, the global malaria drugs market is segmented into prevention, treatment, and other applications such as research & development (R&D) activities carried out by pharmaceutical companies for new drug discovery purposes). The treatment application segment is expected to account for majority share of revenue generated in this market duringthe forecast period from 2018to 2030 owingto high prevalenceofmalaria globallyand rising demandfor effectivetreatment optionsagainstthis disease.
Product Definition:
Malaria drugs are medications used to prevent or treat malaria. Malaria is a serious disease caused by parasites that are spread by mosquitoes. The most common types of malaria parasites are Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. These parasites can infect people of all ages and nationalities.
Aryl Aminoalcohol Compounds:
Aryl amino alcohol compounds are a group of chemicals that includes both non-protein and protein-based compounds. These are also known as sultaine drugs or sultaine derivatives. They have anti-malarial activity and can be used in the treatment of malaria, chloroquine being one such drug example.
Antifolate Compounds:
Antifolate compounds are naturally occurring substances found in plants and some animals. They act as natural inhibitors of folic acid synthesis in the body, which prevents the growth of bacteria that cause malaria. The most commonly used antifolate compound is MALARIA MEDICAMENTUM, a herbal medicine developed by WHO to control malaria caused by Plasmodium vivax and Plasmodium falciparum species of the disease-causing Anopheles mosquito.
Application Insights:
Treatment of malaria was the largest application segment in 2017 and is anticipated to witness significant growth over the forecast period. The increasing incidences of malaria due to increase in Plasmodium falciparum infections as well as other species such as P. vivax and P. ovale across the globe is expected to drive demand for treatment products during the forecast period.
Prevention of Malaria is estimated to be one of the fastest-growing segments owing to extensive government campaigns against mosquito breeding grounds, reduction in personal exposure through indoor residual spraying, and distribution & installation of bed nets among others by various organizations across countries worldwide that are suffering from high incidences of malaria cases including Indonesia, India, Vietnam among others which are expected fuel market growth over next eight years in terms on a global level.
Regional Analysis:
Asia Pacific dominated the global market in 2017. Key factors contributing to its growth include a rise in the number of malaria-endemic countries, increase in healthcare expenditure, and growing awareness about disease transmission. Moreover, increasing demand for artemisinin drugs from China and India is expected to drive regional growth over the forecast period.
The Asia Pacific market was valued at USD X million in 2017 owing to high incidence rates of malaria coupled with rising government spending on health care infrastructure and initiatives pertaining to disease prevention & control measures. In addition, favorable regulations by regulatory bodies such as FDA are anticipated to fuel industry expansion over the coming years.
In 2016, WHO reported an estimated 110 million cases of malaria worldwide with more than 3 lakh deaths recorded during that year alone; hence highlighting need for antimalarial drug manufacturing facilities globally especially within Africa itself (Malaria No More: Ending a Disease Forever).
Growth Factors:
- Increasing prevalence of malaria and its associated health risks is expected to drive the demand for malaria drugs over the forecast period.
- The increasing initiatives by governments and non-profit organizations for malaria prevention and control is also anticipated to boost the market growth.
- Growing R&D investments for novel drug development is likely to provide opportunities for market players over the next few years.
- Rising awareness about available treatment options is projected to propel the demand for malaria drugs in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Malaria Drugs Market Research Report
By Type
Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds
By Application
Prevention, Treatment, Other
By Companies
Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma, Kunming Pharmaceutical, Cipla
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Malaria Drugs Market Report Segments:
The global Malaria Drugs market is segmented on the basis of:
Types
Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Prevention, Treatment, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Kunming Pharmaceutical
- Cipla
Highlights of The Malaria Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- By Application:
- Prevention
- Treatment
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Malaria Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Malaria drugs are medications used to treat malaria.
Some of the major companies in the malaria drugs market are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma, Kunming Pharmaceutical, Cipla.
The malaria drugs market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Malaria Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Malaria Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Malaria Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Malaria Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Malaria Drugs Market Size & Forecast, 2018-2028
4.5.1 Malaria Drugs Market Size and Y-o-Y Growth
4.5.2 Malaria Drugs Market Absolute $ Opportunity
Chapter 5 Global Malaria Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Malaria Drugs Market Size Forecast by Type
5.2.1 Aryl Aminoalcohol Compounds
5.2.2 Antifolate Compounds
5.2.3 Artemisinin Compounds
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Malaria Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Malaria Drugs Market Size Forecast by Applications
6.2.1 Prevention
6.2.2 Treatment
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Malaria Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Malaria Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Malaria Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Malaria Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Malaria Drugs Market Size Forecast by Type
9.6.1 Aryl Aminoalcohol Compounds
9.6.2 Antifolate Compounds
9.6.3 Artemisinin Compounds
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Malaria Drugs Market Size Forecast by Applications
9.10.1 Prevention
9.10.2 Treatment
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Malaria Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Malaria Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Malaria Drugs Market Size Forecast by Type
10.6.1 Aryl Aminoalcohol Compounds
10.6.2 Antifolate Compounds
10.6.3 Artemisinin Compounds
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Malaria Drugs Market Size Forecast by Applications
10.10.1 Prevention
10.10.2 Treatment
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Malaria Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Malaria Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Malaria Drugs Market Size Forecast by Type
11.6.1 Aryl Aminoalcohol Compounds
11.6.2 Antifolate Compounds
11.6.3 Artemisinin Compounds
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Malaria Drugs Market Size Forecast by Applications
11.10.1 Prevention
11.10.2 Treatment
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Malaria Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Malaria Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Malaria Drugs Market Size Forecast by Type
12.6.1 Aryl Aminoalcohol Compounds
12.6.2 Antifolate Compounds
12.6.3 Artemisinin Compounds
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Malaria Drugs Market Size Forecast by Applications
12.10.1 Prevention
12.10.2 Treatment
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Malaria Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Malaria Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Malaria Drugs Market Size Forecast by Type
13.6.1 Aryl Aminoalcohol Compounds
13.6.2 Antifolate Compounds
13.6.3 Artemisinin Compounds
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Malaria Drugs Market Size Forecast by Applications
13.10.1 Prevention
13.10.2 Treatment
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Malaria Drugs Market: Competitive Dashboard
14.2 Global Malaria Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cipla
14.3.2 Guilin Pharmaceutical
14.3.3 IPCA Laboratories
14.3.4 GlaxoSmithKline
14.3.5 Mylan Labs
14.3.6 Roche
14.3.7 Novartis
14.3.8 Sanofi Aventis
14.3.9 Ajanta Pharma
14.3.10 Kunming Pharmaceutical
14.3.11 Cipla
